 - Participants receiving any prohibited medication and who are unwilling or unable to switch to an alternate medication. Note: Any prohibited medications that decrease DTG or RPV concentrations should be discontinued for a minimum of four weeks or a minimum of three half-lives whichever is longer prior to the first dose and any other prohibited medications should be discontinued for a minimum of two weeks or a minimum of three half-lives whichever is longer prior to the first dose. 